@Tdm have you studied the NICE Technical Appraisal 151, dated July 2008, which provides Guidance on the eligibility criteria for insulin pumps? Then see TA 943, Dec 2023, providing Guidance on Hybrid Closed Loop technology.
Rightly or wrongly NICE Guidance is not mandatory direction for the former Cost Centre Groups (CCGs) nor, I presume, for the more regional Integrated Care Boards (ICBs) which overtook CCGs. So there will almost certainly be some form of Guidance from your ICB to give direction to its Health Care Providers (HCPs) about their policy for implementation of TAs 151 and 943.
You mention an e-leaflet that you've been sent. That's pretty vague for anyone on the Forum to comment on. Where did it come from, who has written it? Is that e-leaflet from NICE, the NHS or your own ICB? Is it something any of us can find from a Goigle search to allow others to see? What is the Title?
However, you seem to have answered your own question: your basal consumption is too low along with your HbA1c to allow you to qualify. You could look at thre DAFNE online course as someone who might be interested in getting closed loop and see if that gives you useful information before you meet with the new Consultant later this month.
Preparation and knowledge of the detailed criteria has been key for me in cajoling my HCPs to provide the best care available. It shouldn't be like this, but it is what it is. I know that Oxford have a funded 5 yr plan to provide HCL for those eligible. Whether the funds are enough, whether the professional staff for training and continued supervision exist (or affordable from private companies) is debatable. Whether the Oxford NHS Trust funding will include someone who lives in Berkshire (and possibly not part of the Bucks, Oxford and Berkshire (West) [BOB ICB]) remains to be seen if funds are tight.
I can't help asking what does Tdm stand for,
@Tdm?